A new Trilliant Health report revealed wide disparities in provider payments, with academic medical centers and certain payer-affiliated clinics receiving far higher reimbursements than their peers for the same services. The findings emphasize just how much opaque pricing practices continue to drive inequities in the U.S. healthcare system.
A new Trilliant Health report revealed wide disparities in provider payments, with academic medical centers and certain payer-affiliated clinics receiving far higher reimbursements than their peers for the same services. The findings emphasize just how much opaque pricing practices continue to drive inequities in the U.S. healthcare system.
Sign up and join this webinar that's designed to help registrants understand the ROI of digital health solutions billed as a medical benefit and understand how Solera's model meets the needs of diverse workforces, particularly for employers with 10,000+ staff. Sign up today!
Chiesi Global Rare Diseases is committing up to $115 million to begin a collaboration on Arbor Biotechnologies' in vivo gene-editing therapy for primary hyperoxaluria type 1, an inherited liver disorder. It's the rare disease company's first foray into genetic medicines.
Historically, many medical products and practices have been designed around the male anatomy or physician convenience rather than women's needs, pointed out Abbie Clary, executive director of health for all at CannonDesign.
She cited examples like artificial hips that fail more often in women, as well as CPR mannequins modeled on the male anatomy. There's also the fact that most childbirths take place with the woman on her back — a practice that prioritizes the doctors' ease over women's comfort and physiology.
The best assistive devices for children with sensory processing disorders are those that meet their needs. They will enhance their ability to participate more fully in daily activities.
MedCity News Editor in Chief Arundhati Parmar and Samir Batra, managing partner of Health Innovation Pitch, also discussed whether bitcoin would play a greater role in healthcare deals and the Trump administration's mixed messages on autism and Tylenol.
No comments